PALLESCHI, MICHELA
PALLESCHI, MICHELA
Dottorandi
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): Pilot study with 18F-Fluoroestradiol (18F-FES) CT/PET
In corso di stampa A. Gennari, E. Brain, A. De Censi, O. Nanni, R. Wuerstlein, A. Frassoldati, J. Cortes, V. Rossi, M. Palleschi, J.L. Alberini, F. Matteucci, A. Piccardo, G. Sacchetti, H. Ilhan, F. D’Avanzo, B. Ruffilli, S. Nardin, M. Monti, M. Puntoni, V. Fontana, L. Boni, N. Harbeck,
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study
In corso di stampa Botticelli A, Caputo R, Scagnoli S, Pisegna S, De Laurentiis M, Curigliano G, Lambertini M, Pantano F, Palazzo A, Paris I, Vernieri C, Tedesco B, Giampaglia M, Palleschi M, Ballatore Z, Alesini D, D'Auria G, Fabbri A, Rossi L, Verrazzo A, Scafetta R, Marinelli D, Sposetti C, Barberi V, Strigari L, Marchetti P, Santini D, Fabi A.
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy
2024 Roberta Maltoni; Andrea Roncadori; William Balzi; Massimiliano Mazza; Fabio Nicolini; Michela Palleschi; Paola Ulivi; Sara Bravaccini
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial.
2023 Munzone E, Regan MM, Cinieri S, Montagna E, Orlando L, Shi R, Campadelli E, Gianni L, Palleschi M, Petrelli F, Bengala C, Generali D, Collovà E, Puglisi F, Cretella E, Zamagni C, Chini C, Ruepp B, Loi S, Colleoni M; International Breast Cancer Study Group (IBCSG).
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology
2023 Merloni F.; Palleschi M.; Gianni C.; Casadei C.; Curcio A.; Romeo A.; Rocchi M.; Cima S.; Sirico M.; Sarti S.; Cecconetto L.; Mariotti M.; Di Menna G.; De Giorgi U.
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives
2023 Sirico, Marianna; Virga, Alessandra; Conte, Benedetta; Urbini, Milena; Ulivi, Paola; Gianni, Caterina; Merloni, Filippo; Palleschi, Michela; Gasperoni, Marco; Curcio, Annalisa; Saha, Debjani; Buono, Giuseppe; Muñoz, Montserrat; De Giorgi, Ugo; Schettini, Francesco
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure
2023 Merloni, Filippo; Palleschi, Michela; Casadei, Chiara; Romeo, Antonino; Curcio, Annalisa; Casadei, Roberto; Stella, Franco; Ercolani, Giorgio; Gianni, Caterina; Sirico, Marianna; Cima, Simona; Sarti, Samanta; Cecconetto, Lorenzo; Di Menna, Giandomenico; De Giorgi, Ugo
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer
2023 Gianni C.; Palleschi M.; Merloni F.; Bleve S.; Casadei C.; Sirico M.; Di Menna G.; Sarti S.; Cecconetto L.; Mariotti M.; De Giorgi U.
Real-world experience and clinical impact of drug-drug interactions in HR+/HER2- advanced breast cancer patients treated with abemaciclib plus endocrine therapy: the AB-ITALY study
2023 Pisegna, S.; Scagnoli, S.; Toss, A.; Caputo, R.; De Laurentiis, M.; Palleschi, M.; De Giorgi, U.; Cortesi, E.; Fabbri, M.A.; Fabi, A.; Paris, I.; Orlandi, A.; Curigliano, G.; Criscitiello, C.; Garrone, O.; Tomasello, G.; D{'}Auria, G.; Vici, P.; Ricevuto, E.; Domati, F.; Piombino, C.; Parola, S.; Scafetta, R.; Cirillo, A.; Salimbeni, B.T.; Di Lisa, F.S.; Strigari, L.; Preissner, R.; Simmaco, M.; Santini, D.; Marchetti, P.; Botticelli, A.
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
2023 Schepisi G.; Gianni C.; Palleschi M.; Bleve S.; Casadei C.; Lolli C.; Ridolfi L.; Martinelli G.; De Giorgi U.
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer
2022 Gianni, Caterina; Palleschi, Michela; Merloni, Filippo; Di Menna, Giandomenico; Sirico, Marianna; Sarti, Samanta; Virga, Alessandra; Ulivi, Paola; Cecconetto, Lorenzo; Mariotti, Marita; De Giorgi, Ugo
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment
2022 Gianni C.; Palleschi M.; Schepisi G.; Casadei C.; Bleve S.; Merloni F.; Sirico M.; Sarti S.; Cecconetto L.; Di Menna G.; Schettini F.; De Giorgi U.
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab
2022 Palleschi M.; Prochowski Iamurri A.; Scarpi E.; Mariotti M.; Maltoni R.; Mannozzi F.; Barone D.; Paganelli G.; Casi M.; Giampalma E.; De Giorgi U.; Rocca A.
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis
2022 Rossi T.; Angeli D.; Tebaldi M.; Fici P.; Rossi E.; Rocca A.; Palleschi M.; Maltoni R.; Martinelli G.; Fabbri F.; Gallerani G.
Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
2022 Del Re M.; Omarini C.; Diodati L.; Palleschi M.; Meattini I.; Crucitta S.; Lorenzini G.; Isca C.; Fontana A.; Livi L.; Piacentini F.; Fogli S.; De Giorgi U.; Danesi R.
Body mass index (BMI) and benefit from adjuvant chemotherapy in breast cancer: is it enough?
2021 Palleschi M.; Scarpi E.; Casadei C.
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
2021 Del Re M.; Omarini C.; Diodati L.; Palleschi M.; Meattini I.; Crucitta S.; Lorenzini G.; Isca C.; Fontana A.; Livi L.; Piacentini F.; Fogli S.; De Giorgi U.; Danesi R.
Eribulin in brain metastases of breast cancer: outcomes of the EBRAIM prospective observational trial
2021 Fabi A, Terrenato I, Vidiri A, Villani V, Tanzilli A, Airoldi M, Pedani F, Magri V, Palleschi M, Donadio M, Catania G, Nisticò C, Carapella C, Rudà R, Pace A, Maschio M, Telera S, Cognetti F;
Germline BRCA-mutated metastatic breast cancer with positive hormone receptor
2021 Palleschi M.; Iaia M.L.; Casadei C.
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET)
2021 Vernieri C.; Nichetti F.; Lalli L.; Moscetti L.; Giorgi C.A.; Griguolo G.; Marra A.; Randon G.; Rea C.G.; Ligorio F.; Scagnoli S.; De Angelis C.; Molinelli C.; Fabbri A.; Ferraro E.; Trapani D.; Milani A.; Agostinetto E.; Bernocchi O.; Catania G.; Vantaggiato A.; Palleschi M.; Moretti A.; Basile D.; Cinausero M.; Ajazi A.; Castagnoli L.; Vullo S.L.; Gerratana L.; Puglisi F.; La Verde N.; Arpino G.; Rocca A.; Ciccarese M.; Pedersini R.; Fabi A.; Generali D.; Losurdo A.; Montemurro F.; Curigliano G.; Del Mastro L.; Michelotti A.; Cortesi E.; Guarneri V.; Pruneri G.; Mariani L.; De Braud F.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): Pilot study with 18F-Fluoroestradiol (18F-FES) CT/PET | A. Gennari, E. Brain, A. De Censi, O. Nanni, R. Wuerstlein, A. Frassoldati, J. Cortes, V. Rossi, ...M. Palleschi, J.L. Alberini, F. Matteucci, A. Piccardo, G. Sacchetti, H. Ilhan, F. D’Avanzo, B. Ruffilli, S. Nardin, M. Monti, M. Puntoni, V. Fontana, L. Boni, N. Harbeck, | 9999-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study | Botticelli A, Caputo R, Scagnoli S, Pisegna S, De Laurentiis M, Curigliano G, Lambertini M, Panta...no F, Palazzo A, Paris I, Vernieri C, Tedesco B, Giampaglia M, Palleschi M, Ballatore Z, Alesini D, D'Auria G, Fabbri A, Rossi L, Verrazzo A, Scafetta R, Marinelli D, Sposetti C, Barberi V, Strigari L, Marchetti P, Santini D, Fabi A. | 9999-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |
| An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy | Roberta Maltoni; Andrea Roncadori; William Balzi; Massimiliano Mazza; Fabio Nicolini; Michela Pal...leschi; Paola Ulivi; Sara Bravaccini | 2024-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | biomedicines-12-00498-v2.pdf |
| Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial. | Munzone E, Regan MM, Cinieri S, Montagna E, Orlando L, Shi R, Campadelli E, Gianni L, Palleschi M..., Petrelli F, Bengala C, Generali D, Collovà E, Puglisi F, Cretella E, Zamagni C, Chini C, Ruepp B, Loi S, Colleoni M; International Breast Cancer Study Group (IBCSG). | 2023-01-01 | JAMA ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology | Merloni F.; Palleschi M.; Gianni C.; Casadei C.; Curcio A.; Romeo A.; Rocchi M.; Cima S.; Sirico ...M.; Sarti S.; Cecconetto L.; Mariotti M.; Di Menna G.; De Giorgi U. | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | Merloni_2023.pdf |
| Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives | Sirico, Marianna; Virga, Alessandra; Conte, Benedetta; Urbini, Milena; Ulivi, Paola; Gianni, Cate...rina; Merloni, Filippo; Palleschi, Michela; Gasperoni, Marco; Curcio, Annalisa; Saha, Debjani; Buono, Giuseppe; Muñoz, Montserrat; De Giorgi, Ugo; Schettini, Francesco | 2023-01-01 | CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY | - | 1.01 Articolo in rivista | Sirico_Neoadjuvant endocrine therapy for luminal breast tumors_2023_january.pdf |
| Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure | Merloni, Filippo; Palleschi, Michela; Casadei, Chiara; Romeo, Antonino; Curcio, Annalisa; Casadei..., Roberto; Stella, Franco; Ercolani, Giorgio; Gianni, Caterina; Sirico, Marianna; Cima, Simona; Sarti, Samanta; Cecconetto, Lorenzo; Di Menna, Giandomenico; De Giorgi, Ugo | 2023-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.01 Articolo in rivista | 2023-Merloni (Ther Adv Med Oncol)- Oligometastatic breast cancer REVIEW.pdf |
| Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer | Gianni C.; Palleschi M.; Merloni F.; Bleve S.; Casadei C.; Sirico M.; Di Menna G.; Sarti S.; Cecc...onetto L.; Mariotti M.; De Giorgi U. | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | Potential Impact of Preoperative Circulating Biomarkers.pdf |
| Real-world experience and clinical impact of drug-drug interactions in HR+/HER2- advanced breast cancer patients treated with abemaciclib plus endocrine therapy: the AB-ITALY study | Pisegna, S.; Scagnoli, S.; Toss, A.; Caputo, R.; De Laurentiis, M.; Palleschi, M.; De Giorgi, U.;... Cortesi, E.; Fabbri, M.A.; Fabi, A.; Paris, I.; Orlandi, A.; Curigliano, G.; Criscitiello, C.; Garrone, O.; Tomasello, G.; D{'}Auria, G.; Vici, P.; Ricevuto, E.; Domati, F.; Piombino, C.; Parola, S.; Scafetta, R.; Cirillo, A.; Salimbeni, B.T.; Di Lisa, F.S.; Strigari, L.; Preissner, R.; Simmaco, M.; Santini, D.; Marchetti, P.; Botticelli, A. | 2023-01-01 | ANNALS OF ONCOLOGY | - | 1.06 Abstract in rivista | - |
| The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer | Schepisi G.; Gianni C.; Palleschi M.; Bleve S.; Casadei C.; Lolli C.; Ridolfi L.; Martinelli G.; ...De Giorgi U. | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | - |
| Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer | Gianni, Caterina; Palleschi, Michela; Merloni, Filippo; Di Menna, Giandomenico; Sirico, Marianna;... Sarti, Samanta; Virga, Alessandra; Ulivi, Paola; Cecconetto, Lorenzo; Mariotti, Marita; De Giorgi, Ugo | 2022-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | graphic.pdf; ijms-23-14197.pdf |
| Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment | Gianni C.; Palleschi M.; Schepisi G.; Casadei C.; Bleve S.; Merloni F.; Sirico M.; Sarti S.; Cecc...onetto L.; Di Menna G.; Schettini F.; De Giorgi U. | 2022-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab | Palleschi M.; Prochowski Iamurri A.; Scarpi E.; Mariotti M.; Maltoni R.; Mannozzi F.; Barone D.; ...Paganelli G.; Casi M.; Giampalma E.; De Giorgi U.; Rocca A. | 2022-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | - |
| Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis | Rossi T.; Angeli D.; Tebaldi M.; Fici P.; Rossi E.; Rocca A.; Palleschi M.; Maltoni R.; Martinell...i G.; Fabbri F.; Gallerani G. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-03925-v2.pdf; cancers-14-03925-s001.zip |
| Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients | Del Re M.; Omarini C.; Diodati L.; Palleschi M.; Meattini I.; Crucitta S.; Lorenzini G.; Isca C.;... Fontana A.; Livi L.; Piacentini F.; Fogli S.; De Giorgi U.; Danesi R. | 2022-01-01 | ESMO OPEN | - | 1.04 Replica / breve intervento (e simili) | - |
| Body mass index (BMI) and benefit from adjuvant chemotherapy in breast cancer: is it enough? | Palleschi M.; Scarpi E.; Casadei C. | 2021-01-01 | BREAST CANCER RESEARCH AND TREATMENT | - | 1.01 Articolo in rivista | - |
| Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients | Del Re M.; Omarini C.; Diodati L.; Palleschi M.; Meattini I.; Crucitta S.; Lorenzini G.; Isca C.;... Fontana A.; Livi L.; Piacentini F.; Fogli S.; De Giorgi U.; Danesi R. | 2021-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | - |
| Eribulin in brain metastases of breast cancer: outcomes of the EBRAIM prospective observational trial | Fabi A, Terrenato I, Vidiri A, Villani V, Tanzilli A, Airoldi M, Pedani F, Magri V, Palleschi M, ...Donadio M, Catania G, Nisticò C, Carapella C, Rudà R, Pace A, Maschio M, Telera S, Cognetti F; | 2021-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Germline BRCA-mutated metastatic breast cancer with positive hormone receptor | Palleschi M.; Iaia M.L.; Casadei C. | 2021-01-01 | BREAST CANCER RESEARCH AND TREATMENT | - | 1.04 Replica / breve intervento (e simili) | - |
| Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) | Vernieri C.; Nichetti F.; Lalli L.; Moscetti L.; Giorgi C.A.; Griguolo G.; Marra A.; Randon G.; R...ea C.G.; Ligorio F.; Scagnoli S.; De Angelis C.; Molinelli C.; Fabbri A.; Ferraro E.; Trapani D.; Milani A.; Agostinetto E.; Bernocchi O.; Catania G.; Vantaggiato A.; Palleschi M.; Moretti A.; Basile D.; Cinausero M.; Ajazi A.; Castagnoli L.; Vullo S.L.; Gerratana L.; Puglisi F.; La Verde N.; Arpino G.; Rocca A.; Ciccarese M.; Pedersini R.; Fabi A.; Generali D.; Losurdo A.; Montemurro F.; Curigliano G.; Del Mastro L.; Michelotti A.; Cortesi E.; Guarneri V.; Pruneri G.; Mariani L.; De Braud F. | 2021-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |